HDV-HBV interaction |
L-HDAg ↔ S-HBsAg |
HDV assembly |
92, 93 |
S/L-HDAg ↔ HBV enhancers Enh1/2 |
HBV suppression |
97 |
HDV-interaction with host factors |
L-HDAg ↔ DNA dependent RNA-polymerase II |
HBV suppression |
96 |
L-HDAg ↔ genes of SRE-dependent pathway |
HBV suppression |
95 |
S/L-HDAg ↔ MxA |
Induction innate immune responses, HBV suppression |
97 |
HDV ↔ ISGs, signaling genes, cytokines |
Induction innate immune responses, HBV suppression |
107 |
HBV-interaction with host factors |
HBsAg ↔ NFκB, TNF-α, ER-stress pathway |
Translocation of HDV from nucleus to ER, HDV assembly |
94 |
HBsAg ↔ TLR signaling |
Suppression TLR signaling |
110, 111 |
HBeAg ↔ TLR2 |
Impairment innate immune responses |
109 |
HBV ↔ cellular DNA methyltransferases |
Epigenetic modifications |
115, 116 |
HBx protein ↔ innate signaling pathways |
Impairment innate immune responses |
117 |
HBV ↔ STAT translocation |
Impairment IFN signaling |
112, 113 |